Annual report pursuant to Section 13 and 15(d)

Convertible Notes Payable (Details Narrative)

v3.20.1
Convertible Notes Payable (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Jan. 31, 2018
Nov. 24, 2017
May 31, 2018
May 21, 2018
Dec. 31, 2019
Dec. 31, 2018
Debt conversion price per share     $ 1.90      
Gross proceeds from convertible debt         $ 6,638 $ 7,684
Sale of common stock, net of transaction costs         $ 6,638 $ 7,684
Shares issued price per share         $ 0.50  
8% Convertible Notes [Member]            
Number of common stock shares converted       1,085,105    
Board of Directors [Member]            
Convertible note interest rate, percentage     8.00%      
Debt conversion price per share     $ 1.90      
Accrued interest     $ 2,062      
Board of Director [Member]            
Number of common stock shares converted     1,085,105      
Securities Purchase Agreement [Member]            
Sale of common stock, net of transaction costs     $ 4,435,527      
Shares issued price per share     $ 1.90      
Proceeds from issuance of public offering     $ 7,680      
Securities Purchase Agreement [Member] | Convertible Notes Payable [Member] | OPKO Health, Inc. [Member]            
Debt instrument, principal amount $ 1,000          
Additional principal amount of debt $ 1,000          
Debt maturity date Jan. 31, 2020          
Debt conversion price per share $ 8.10          
Gross proceeds from convertible debt $ 10,000          
Securities Purchase Agreement [Member] | Two Investors [Member] | Convertible Notes [Member]            
Debt instrument, principal amount   $ 1,000        
Convertible note interest rate, percentage   8.00%        
Additional principal amount of debt   $ 1,000        
Debt maturity date   Nov. 24, 2019        
Debt conversion price per share   $ 8.10        
Gross proceeds from convertible debt   $ 10,000